Inventor · disambiguated record
Andrew W. Fraley
Also filed as: FRALEY ANDREW · FRALEY ANDREW W · FRALEY PH D ANDREW W
14 granted patents·36 pending applications·172 citations·filing 2002–2025
91Inventor score
Files withKORRO BIO INC25MODERNA THERAPEUTICS INC13MODERNATX INC9ENSEMBLE THERAPEUTICS CORP1JUDO BIO INC1
Top patents by PatentIndex Score
50 records- 0198US10286086B2Alternative nucleic acid molecules and uses thereofMODERNATX INC·Filed 2015·Granted May 14, 2019·78 cites·14 claims
- 0295US11479575B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2020·Granted Oct 25, 2022·5 cites·17 claims
- 0395US10385088B2Polynucleotide molecules and uses thereofMODERNATX INC·Filed 2014·Granted Aug 20, 2019·66 cites·12 claims
- 0494US11453878B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2020·Granted Sep 27, 2022·5 cites·18 claims
- 0593US12031131B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2023·Granted Jul 9, 2024·1 cites·27 claims
- 0692US12448620B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2022·Granted Oct 21, 2025·1 cites·20 claims
- 0792US12173285B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2023·Granted Dec 24, 2024·1 cites·28 claims
- 0892US12152050B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2022·Granted Nov 26, 2024·1 cites·17 claims
- 0989US10407683B2Circular polynucleotidesMODERNATX INC·Filed 2015·Granted Sep 10, 2019·9 cites·21 claims
- 1085US2025382610A1Rna-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2025·Application pending·0 cites
- 1184US2024165267A1Modified nucleic acid molecules and uses thereofMODERNATX INC·Filed 2022·Application pending·0 cites
- 1283US2025215038A1Rna-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2024·Application pending·0 cites
- 1380US2025066773A1Rna-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2024·Application pending·0 cites
- 1477US2025186624A1Polynucleotides containing a stabilizing tail regionMODERNATX INC·Filed 2024·Application pending·0 cites
- 1575US11434486B2Polynucleotides containing a morpholino linkerMODERNATX INC·Filed 2016·Granted Sep 6, 2022·1 cites·23 claims
- 1672US12071620B2Polynucleotides containing a morpholino linkerMODERNATX INC·Filed 2022·Granted Aug 27, 2024·0 cites·20 claims
- 1768US6914052B2Selective anti-viral nucleoside chain terminatorsTRUSTEES BOSTON COLLEGE·Filed 2002·Granted Jul 5, 2005·4 cites·17 claims
- 1868US2025034563A1Methods and Compositions for ADAR-Mediated EditingKORRO BIO INC·Filed 2022·Application pending·0 cites
- 1967US2025034564A1Methods and Compositions for ADAR-Mediated EditingKORRO BIO INC·Filed 2022·Application pending·0 cites
- 2067US2015307542A1Modified nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2166US2016354493A1Modified nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2266US2016354491A1Modified nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2366US2016348099A1Modified nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2466US2025388903A1Methods and Compositions for Adar-Mediated EditingKORRO BIO INC·Filed 2025·Application pending·0 cites
- 2565US2016354492A1Modified nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2665US2016354490A1Modified nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2764US2023257752A1Methods and compositions for the adar-mediated editing of argininosuccinate synthetase (ass1)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 2864US2023272376A1Methods and compositions for the adar-mediated editing of methyl-cpg binding protein 2 (mecp2)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 2964US2023295664A1Methods and compositions for the adar-mediated editing of leucine rich repeat kinase 2 (lrrk2)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 3064US2023295614A1Methods and compositions for the adar-mediated editing of argininosuccinate lyase (asl)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 3164US2023272384A1Methods and compositions for the adar-mediated editing of retinochisin 1 (rs1)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 3264US2025213604A1Targeted deliveryJUDO BIO INC·Filed 2023·Application pending·0 cites
- 3364US2023212569A1Methods and compositions for the adar-mediated editing of otoferlin (otof)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 3464US2023272377A1Methods and compositions for the adar-mediated editing of transmembrane channel-like protein 1 (tmc1)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 3564US2023272383A1Methods and compositions for the adar-mediated editing of gap junction protein beta 2 (gjb2)KORRO BIO INC·Filed 2022·Application pending·0 cites
- 3663US2024263177A1Methods and Compositions for Adar-Mediated EditingKORRO BIO INC·Filed 2022·Application pending·0 cites
- 3762US2020385713A1Rna-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2020·Application pending·0 cites
- 3862US2022307027A1RNA-Editing Enzyme-Recruiting Oligonucleotides and Uses ThereofKORRO BIO INC·Filed 2022·Application pending·0 cites
- 3959US12109274B2Polynucleotides containing a stabilizing tail regionMODERNATX INC·Filed 2016·Granted Oct 8, 2024·0 cites·9 claims
- 4057US2023174989A1Methods and Compositions for the ADAR-Mediated Editing of ABCA4KORRO BIO INC·Filed 2021·Application pending·0 cites
- 4157US2021380980A1Methods and Compositions for the ADAR-Mediated Editing of SERPINA1KORRO BIO INC·Filed 2021·Application pending·0 cites
- 4256US2019255194A1Alternative nucleic acid molecules and uses thereofMODERNATX INC·Filed 2019·Application pending·0 cites
- 4353US2016304552A1Modified nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4452US2015167017A1Alternative nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4550US9605022B2Macrocyclic compounds for inhibition of inhibitors of apoptosisENSEMBLE THERAPEUTICS CORP·Filed 2013·Granted Mar 28, 2017·0 cites·11 claims
- 4650US2016194625A1Chimeric polynucleotidesMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4746US2016264614A1Polynucleotide molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4838US2017136132A1Alternative nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4935US2017175129A1Alternative nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 5035US2017204152A1Chimeric polynucleotidesMODERNA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew W. Fraley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →